It was the third failed trial for the therapy, called dalzanemdor, which also failed to meet its goals in a Phase 2 trial as ...

Diagnosed prevalent cases of Parkinson’s disease will grow at 1.94% annually in the seven major markets between 2023 and 2033 ...

Parkinson’s disease is a neurodegenerative disorder that impacts a million people living in the United States today. While most people are over the age of 60 when they’re diagnosed, one in 10 people ...

A recently published study found that a tiny protein called PNA5 appears to have a protective effect on brain cells, which could lead to treatments for the cognitive symptoms of Parkinson's disease ...

A recently published study by researchers at the University of Arizona Health Sciences found that a tiny protein called PNA5 ...

The former Australian Test skipper revealed his battle with the incurable disease in a brave message made in June last year.

Gain Therapeutics, Inc. ( (GANX) ) has released its Q3 earnings. Here is a breakdown of the information Gain Therapeutics, Inc. presented to ...

Michael J. Fox is keeping his wit through his struggle with Parkinson’s Disease. At his Foundation’s annual A Funny Thing ...

ImPULS generates high-frequency sound waves to activate brain cells and help reconnect broken circuits and, ultimately, help ...

A recently published study by researchers at the University of Arizona Health Sciences found that a tiny protein called PNA5 ...

News on Inhibikase's promising treatments for PAH and Parkinson's Disease, supported by FDA approval and substantial funding.